Dr. Shibata serves as Senior Bioinformatics Scientist. He joined GeneCentric Therapeutics in 2017 after completing his post-doctoral training at the University of North Carolina at Chapel Hill where he combined various genome-wide sequencing and experimental molecular techniques to understand the epigenetic dynamics of meiosis and disease. At GeneCentric, he oversees research analysis pipeline design, implementation and assay development. Dr. Shibata received his PhD in Genetics and Genomics from Duke University.